1-20 of 20
Brian Hill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Superior real-world outcomes of lisocabtagene maraleucel in chronic lymphocytic leukemia

Free
Jennifer Huang, Jenna Voutsinas, Niranjan Khaire, Vincenzo Pizzuti, Leyla Shune, Matthew Lei, Rodrigo Fonseca, Mohammad Ammad Ud Din, Alan Skarbnik, Agrima Mian, Sushma Bharadwaj, Aseel Alsouqi, Bret Wankel, Graham Wehmeyer, Joseph Lukowski, Alexey Danilov, Tanya Siddiqi, Meghan Thompson, Michael Scordo, Stephanie Franco, Deborah Stephens, Chaitra Ujjani, Ryan Lynch, Jordan Gauthier, William Wierda, Paul Barr, Adam Kittai, Jonah Shulman, Matthew Lunning, Kerry Rogers, Bita Fakhri, Brian Hill, Javier Pinilla-Ibarz, Talal Hilal, Jacob Soumerai, Manali Kamdar, Qian Wu, Nitin Jain, Mazyar Shadman
Journal: Blood
Blood (2025) 146 (Supplement 1): 798.
https://doi.org/10.1182/blood-2025-798
Published: 2025
Journal Articles

Two-year update of ZUMA-2 Cohort 3: Brexucabtagene autoleucel (Brexu-cel) in patients (pts) with relapsed/refractory mantle cell lymphoma (R/R MCL) who had not received prior Bruton tyrosine kinase inhibitor (BTKi) therapy

Free
Tom Van Meerten, Marie José Kersten, Gloria Iacoboni, Georg Hess, Pim Mutsaers, Alejandro Martin Garcia-Sancho, Andre Goy, Eva Gine, Brian Hill, Wen-Kai Weng, Martin Dreyling, Patrick Reagan, Krish Patel, Ahmed Galal, Charles Herbaux, Robin Sanderson, Dan Zheng, Sabina Adhikary, Wangshu Zhang, Rita Damico Khalid, Ioana Kloos, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1799.
https://doi.org/10.1182/blood-2025-1799
Published: 2025
Journal Articles

Comparison of real-world survival outcomes and time toxicity of CAR T-cell versus bispecific antibody therapies in relapsed/refractory follicular lymphoma: A multicenter cohort from 15 US academic institutions

Free
Ajay Major, Diana Abbott, Jordan Snyder, Nausheen Ahmed, Alline Amorim, Jose Villasboas Bisneto, John Sharp, Timothy Voorhees, Samin Houshyar, Danielle Wallace, Arjab Adhikari, Dilan Patel, Christopher Wanjiku, Charlotte Wagner, Allison Bock, Taylor Brooks, Haya Al Any, Mazie Tsang, Mohamed Rajab, Madiha Iqbal, Nidhi Desai, Supriya Gupta, Nicole Altomare, Reem Karmali, Daniel Trotier, Priyanka Pophali, Edd Ricker, Hua-Jay Cherng, Arjun Gupta, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 1798.
https://doi.org/10.1182/blood-2025-1798
Published: 2025
Journal Articles

Twelve month landmark analysis of outcomes of relapsed or refractory large B-cell lymphoma patients achieving prolonged remission with glofitamab or epcoritamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study

Free
Taylor Brooks, Adrienne Nedved, Yucai Wang, Natalie Grover, XI Yang, Yasmin Karimi, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Alyssa Gibson, Justin Kline, Javier Munoz, Rodolfo Garza Morales, Eiraj Khan, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 4499.
https://doi.org/10.1182/blood-2025-4499
Published: 2025
Journal Articles

Real-time interleukin-6 (IL-6) kinetics predict cytokine release syndrome (CRS) in patients receiving chimeric antigen receptor (CAR) T-cell therapy for Relapsed/Refractory B-cell malignancies

Free
Agrima Mian, Rafaella Ferreira De Araujo Litvin, Jessica Colon-Franco, Sujata Patil, Megan Molnar, Allison Winter, Sandra Mazzoni, Robert Dean, Louis Williams, Aaron Gerds, John Molina, Shahzad Raza, Faiz Anwer, Deepa Jagadeesh, Betty K. Hamilton, Claudio Brunstein, Brian Hill, Paolo Caimi
Journal: Blood
Blood (2025) 146 (Supplement 1): 2397.
https://doi.org/10.1182/blood-2025-2397
Published: 2025
Journal Articles

Multi-center real world analysis of treatment outcomes of non-COVALENT btki, pirtobrutinib, in patients with COVALENT btki relapsed/refracdtory Mantle Cell Lymphoma

Free
Paolo Lopedote, Adrienne Nedved, Lu Chen, Marcus Watkins, Arian Roua, Muhamad Alhaj Moustafa, Seyi Abidoye, Yun Choi, Georgios Pongas, Tony Zhuang, Jean Clement, Megan Searssmith, Laura Sun, Hannah Willis, Brad Kahl, David Bond, Javier Munoz, Izidore S. Lossos, Craig Portell, Michael Wang, Nilanjan Ghosh, Jonathon Cohen, Peter Martin, Jeremy Abramson, Anne Beaven, Patrick Reagan, Daniel Ermann, Taylor Brooks, Ashlee Joseph, Nazila Shafagati, Daniel McLoughlin, Kira Rosenlind, Brian Hill, Nina Wagner-Johnston, Anita Kumar, Umar Farooq, Reem Karmali, Tanaya Shree, Matthew Lunning, Stacy Pak, Alexey Danilov, Yucai Wang, Tycel Phillips
Journal: Blood
Blood (2025) 146 (Supplement 1): 5351.
https://doi.org/10.1182/blood-2025-5351
Published: 2025
Journal Articles

Evaluation of ventoclax initiation prophylaxis and monitoring outcomes at each dose level and time point in patients with chronic lymphocytic leukemia: A real-world experience

Free
Christopher Jensen, Mazyar Shadman, Andres Chang, Nicole Lamanna, Beenish Manzoor, Chaitra Ujjani, Deborah Stephens, Wendy Sinai, Brian Hill, Jennifer Brown, Hande Tuncer, Matthew S Davids, Toby Eyre, Nicolas Martinez-Calle, Lori Leslie, Lindsey Roeker, Paul Barr, Nnadozie Emechebe, Alan Skarbnik, Bita Fakhri, Meghan Thompson, Joanna Rhodes, Isabelle Fleury, Frederick Lansigan, Robson Lima, Zhu Cui, Michael Coyle, Samin Houshyar, Laurie Pearson, Irina Pivneva, Talissa Watson, Annie Guerin, Nilanjan Ghosh
Journal: Blood
Blood (2025) 146 (Supplement 1): 3885.
https://doi.org/10.1182/blood-2025-3885
Published: 2025
Journal Articles

Infection risk factors and burden in patients treated with T-cell engaging bispecific antibodies for relapsed B-cell lymphoma and multiple myeloma

Free
Rafaella Ferreira De Araujo Litvin, Agrima Mian, Ran Zhao, Kelsey Pandrangi, Kristina Nasr, Sharan Jhaveri, Mikhaila Rice, Joslyn Rudoni, Allison Winter, Deepa Jagadeesh, Robert Dean, Taylor Brooks, Louis Williams, Shahzad Raza, Faiz Anwer, Jason Valent, Christy Samaras, John Molina, Betty K. Hamilton, Claudio Brunstein, Brian Hill, Sandra Mazzoni, Jack Khouri, Paolo Caimi
Journal: Blood
Blood (2025) 146 (Supplement 1): 2814.
https://doi.org/10.1182/blood-2025-2814
Published: 2025
Journal Articles

Prognostic factors and survival outcomes of urgent inpatient chemotherapy for relapsed/refractory lymphoma in the modern era

Free
Abhishek Kataria, Mikhaila Rice, Wei Wei, Faiz Anwer, Paolo Caimi, Allison Winter, Robert Dean, Taylor Brooks, Joslyn Rudoni, Jack Khouri, Christy Samaras, Shahzad Raza, Sandra Mazzoni, Jason Valent, Brian Hill, Deepa Jagadeesh
Journal: Blood
Blood (2025) 146 (Supplement 1): 2737.
https://doi.org/10.1182/blood-2025-2737
Published: 2025
Journal Articles

Outcomes of urgent inpatient chemotherapy for relapsed/refractory multiple myeloma in the modern era

Free
Abhishek Kataria, Mikhaila Rice, Wei Wei, Faiz Anwer, Paolo Caimi, Allison Winter, Robert Dean, Taylor Brooks, Joslyn Rudoni, Jack Khouri, Christy Samaras, Shahzad Raza, Sandra Mazzoni, Jason Valent, Brian Hill, Louis Williams, Deepa Jagadeesh
Journal: Blood
Blood (2025) 146 (Supplement 1): 4601.
https://doi.org/10.1182/blood-2025-4601
Published: 2025
Journal Articles

Real-world outcomes of glofitamab (Glofit) plus gemcitabine and oxaliplatin (GemOx) in Relapsed/Refractory (R/R) aggressive B-cell lymphoma (BCL): A multicenter retrospective study from the United States

Free
Yun Kyoung Tiger, Roshan Asrani, Graham Wehmeyer, Robert Ryan, Ajay Major, Natalie Grover, Kelsey Baron, Talal Hilal, Adrienne Nedved, Taylor Brooks, Arjun Ravishankar, Tarsheen Sethi, Brian Hill, Yucai Wang, Allison Bock, Adam Kittai, Matthew Matasar, Joanna Rhodes
Journal: Blood
Blood (2025) 146 (Supplement 1): 1956.
https://doi.org/10.1182/blood-2025-1956
Published: 2025
Journal Articles

Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial)

Free
Matthew Frank, David Qualls, Armin Ghobadi, Jordan Gauthier, Michael Tees, Luke Mountjoy, Joseph McGuirk, Sattva Neelapu, Reem Karmali, Iris Isufi, Brian Hill, Craig Sauter, Catherine Diefenbach, Jay Spiegel, Lizamarie Bachier-Rodriguez, Monalisa Ghosh, Nirav Shah, Rahul Lakhotia, Francisco Hernandez-Ilizaliturri, Anuja Abhyankar, Elise Chong, Matthew Schwede, Krish Patel, Olalekan Oluwole, John Baird, Nathan Denlinger, Farrukh Awan, Michael Jain, John Timmerman, Cesar Sanchez, Muthu Kumaran, Jean Yared, Jon Arnason, Ishan Tatake, Usama Gergis, Peter Riedell, Keith Pratz, Nirali Shah
Journal: Blood
Blood (2025) 146 (Supplement 1): 667.
https://doi.org/10.1182/blood-2025-667
Published: 2025
Journal Articles

Outcomes following disease progression after epcoritamab or glofitamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study

Free
Taylor Brooks, Agrima Mian, Adrienne Nedved, Yucai Wang, Natalie Grover, XI Yang, Yasmin Karimi, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Alyssa Gibson, Justin Kline, Javier Munoz, Rodolfo Garza Morales, Eiraj Khan, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 402.
https://doi.org/10.1182/blood-2025-402
Published: 2025
Journal Articles

Risk factors for cytokine release syndrome and neurotoxicity in patients receiving epcoritamab or glofitamab for large B cell lymphoma: A multi-center, retrospective, real world analysis.

Free
XI Yang, Yasmin Karimi, Xiaoying Chen, Adrienne Nedved, Yucai Wang, Natalie Grover, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Justin Kline, Alyssa Gibson, Javier Munoz, Raja Prince-Eladnani, Rodolfo Garza Morales, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill, Taylor Brooks
Journal: Blood
Blood (2025) 146 (Supplement 1): 401.
https://doi.org/10.1182/blood-2025-401
Published: 2025
Journal Articles

Venetoclax retreatment of real-world patients with chronic lymphocytic leukemia previously treated with venetoclax-based regimens

Free
Mazyar Shadman, Meghan Thompson, Nilanjan Ghosh, Nnadozie Emechebe, Beenish Manzoor, Godwin Okoye, Neto Coulibaly, Wendy Sinai, Sophia Li, Rajesh Kamalakar, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 2108.
https://doi.org/10.1182/blood-2025-2108
Published: 2025
Journal Articles

Real-world response and toxicity profiles of sequential bispecific antibody therapies in Relapsed/Refractory multiple myeloma

Free
Agrima Mian, Rafaella Ferreira De Araujo Litvin, Kelsey Pandrangi, Kristina Nasr, Sharan Jhaveri, Mikhaila Rice, Joslyn Rudoni, Louis Williams, Christy Samaras, John Molina, Betty K. Hamilton, Shahzad Raza, Faiz Anwer, Jason Valent, Claudio Brunstein, Brian Hill, Paolo Caimi, Sandra Mazzoni
Journal: Blood
Blood (2025) 146 (Supplement 1): 6376.
https://doi.org/10.1182/blood-2025-6376
Published: 2025
Journal Articles

Patient-reported outcomes (PROs) with lisocabtagene maraleucel (liso-cel) in patients with third line or later (3L+) R/R MZL from the Phase 2 TRANSCEND FL study

Free
Reem Karmali, Franck Morschhauser, Koji Izutsu, Lia Palomba, Kirit Ardeshna, Brian Hill, Manali Kamdar, Stephen J. Schuster, Antonio Pinto, Saurabh Dahiya, Merav Bar, Maria Strocchia, Jinender Kumar, Jeremy Abramson
Journal: Blood
Blood (2025) 146 (Supplement 1): 709.
https://doi.org/10.1182/blood-2025-709
Published: 2025
Journal Articles

Severe neutropenia after treatment with T-cell engaging bispecific antibodies is associated with higher rates of CRS and disease response

Free
Rafaella Ferreira De Araujo Litvin, Agrima Mian, Ran Zhao, Kelsey Pandrangi, Kristina Nasr, Sharan Jhaveri, Mikhaila Rice, Joslyn Rudoni, Allison Winter, Deepa Jagadeesh, Robert Dean, Taylor Brooks, Louis Williams, Shahzad Raza, Faiz Anwer, Jason Valent, Christy Samaras, John Molina, Betty K. Hamilton, Claudio Brunstein, Brian Hill, Sandra Mazzoni, Jack Khouri, Paolo Caimi
Journal: Blood
Blood (2025) 146 (Supplement 1): 6350.
https://doi.org/10.1182/blood-2025-6350
Published: 2025
Journal Articles

Safety and efficacy of transposon, BAFF-ligand directed chimeric antigen receptor T cells (LMY-920) with pre-apheresis obinutuzumab for patients with Relapsed/Refractory chronic lymphocytic leukemia and small lymphocytic lymphoma

Free
Paolo Caimi, Leland Metheny, Lapo Alinari, Changchun Deng, Matthew Spear, Jeff Liter, Branden Moriarity, Beau Webber, Jennifer Woyach, Brian Hill, J. Joseph Melenhorst
Journal: Blood
Blood (2025) 146 (Supplement 1): 4177.
https://doi.org/10.1182/blood-2025-4177
Published: 2025
Journal Articles

Longitudinal Characterization of Hemodynamic Changes with Multimodal Optical Techniques in Patients with Sickle Cell Disease Treated with Mitapivat

Free
Timothy Quang, Ingrid Frey, Julia Xu, Golnar Mostashari, Anna Conrey, Dina S. Parekh, Ruth Pierre Charles, Brian Hill, Swee Lay Thein, Bruce J Tromberg
Journal: Blood
Blood (2023) 142 (Supplement 1): 2492.
https://doi.org/10.1182/blood-2023-174227
Published: 2023